Susquehanna Fundamental Investments’s Accelerate Diagnostics AXDX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,154	Closed	-$126K	–	1433
2021 Q3	$126K	Sell	2,154 -133	-6%	-$8.67K	﹤0.01%	1602
2021 Q2	$184K	Buy	+2,287	New	+$182K	﹤0.01%	1502
2020 Q4	–	Sell	-1,740	Closed	-$185K	–	1495
2020 Q3	$185K	Hold	1,740	–	–	0.01%	1211
2020 Q2	$264K	Buy	+1,740	New	+$172K	0.01%	773

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Susquehanna Fundamental Investments's AXDX Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Accelerate Diagnostics (AXDX) in Q4 2021, closing a stake of 2,154 shares — an estimated $126K sold.

Susquehanna Fundamental Investments first reported a position in AXDX in Q2 2020 and held it in 4 quarters. The position peaked at $264K in Q2 2020. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2021.

Susquehanna Fundamental Investments reported no remaining Accelerate Diagnostics position as of Q4 2021 after selling out during the quarter.
Susquehanna Fundamental Investments sold 2,154 Accelerate Diagnostics shares in Q4 2021, an estimated $126K.
Susquehanna Fundamental Investments first reported a position in Accelerate Diagnostics in Q2 2020 and held it in 4 quarters.
Susquehanna Fundamental Investments's Accelerate Diagnostics position peaked at $264K in Q2 2020.
107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.